DC-SIGN/CD209 Antikörper (N-Term)
Kurzübersicht für DC-SIGN/CD209 Antikörper (N-Term) (ABIN927998)
Target
Alle DC-SIGN/CD209 (CD209) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Aufreinigung
- Purified
-
Immunogen
- CD209 antibody was raised in rabbit using the N terminal of CD209 as the immunogen
-
-
-
-
Applikationshinweise
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
CD209 Blocking Peptide, , is also available for use as a blocking control in assays to test for specificity of this CD209 antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- DC-SIGN/CD209 (CD209) (CD209)
-
Andere Bezeichnung
- CD209
-
Hintergrund
- This gene encodes a transmembrane receptor and is often referred to as DC-SIGN because of its expression on the surface of dendritic cells and macrophages. The encoded protein is involved in the innate immune system and recognizes numerous evolutionarily divergent pathogens ranging from parasites to viruses with a large impact on public health. Synonyms: Polyclonal CD209 antibody, Anti-CD209 antibody, CD209 molecule antibody, CDSIGN antibody, CLEC4L antibody, DC-SIGN antibody, DC-SIGN1 antibody, MGC129965 antibody.
Target
-